[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100093560":3},{"organization":4,"armGroups":7,"interventions":8,"overallOfficials":11,"centralContacts":7,"locations":7,"responsibleParty":15,"collaborators":17,"id":21,"slug":22,"hasResults":23,"nctId":24,"briefTitle":25,"officialTitle":26,"acronym":7,"eligibilityCriteria":27,"healthyVolunteers":28,"sex":29,"minAge":7,"maxAge":7,"enrollmentInfo":30,"targetDuration":7,"studyType":33,"phases":34,"briefSummary":36,"conditions":37,"keywords":39,"overallStatus":41,"whyStopped":7,"lastUpdateSubmitDate":42,"lastUpdatePostDateStruct":43,"startDateStruct":45,"completionDateStruct":47,"leadSponsor":50,"locationsCount":7},{"fullName":5,"class":6},"City of Hope Medical Center","OTHER",null,[9],{"type":6,"name":10,"description":7,"armGroupLabels":7,"otherNames":7},"survey administration",[12],{"name":13,"affiliation":5,"role":14},"Arti Hurria, MD","PRINCIPAL_INVESTIGATOR",{"type":7,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":16,"oldOrganization":5},"Arti Hurria MD",[18],{"name":19,"class":20},"National Cancer Institute (NCI)","NIH","100093560","views-and-attitudes-of-oncologists-and-geriatricians-on-the-use-of-chemotherapy-and-hormone-therapy-in-treating-older-andor-frail-women-with-breast-cancer-100093560",false,"NCT00478283","Views and Attitudes of Oncologists and Geriatricians on the Use of Chemotherapy and Hormone Therapy in Treating Older and\u002For Frail Women With Breast Cancer","Perspectives and Attitudes on the Use of Adjuvant Chemotherapy and Hormonal Therapy in Older and\u002For Frail Women: A Survey of Oncologists and Geriatricians","DISEASE CHARACTERISTICS:\n\n* Participants must meet 1 of the following criteria:\n\n  * Oncologist:\n\n    * Must have been in practice ≥ 2 years\n    * Must have ≥ 25 postmenopausal breast cancer patients on adjuvant hormonal therapy\n    * Cannot work for an advertising agency, market research company, manufacturer or distributor of pharmaceutical products, a pharmacy, drug store, or the FDA\n  * Geriatrician:\n\n    * Must have been in practice ≥ 2 years\n    * Must be a general practitioner, family practitioner, internal medicine specialist, or geriatrician and received a certificate of added qualification in geriatric medicine and\u002For treating at least 5 postmenopausal patients who have a history of breast cancer or are currently undergoing treatment for breast cancer\n    * Cannot work for an advertising agency, market research company, manufacturer or distributor of pharmaceutical products, a pharmacy, drug store, or the FDA\n\nPATIENT CHARACTERISTICS:\n\n* Not specified\n\nPRIOR CONCURRENT THERAPY:\n\n* Not specified",true,"ALL",{"count":31,"type":32},300,"ESTIMATED","INTERVENTIONAL",[35],"NA","RATIONALE: A patient's age, health, and ability to perform daily activities may affect which treatment options are offered by doctors to older and\u002For frail women with breast cancer.\n\nPURPOSE: This clinical trial is studying the views and attitudes of oncologists and geriatricians on the use of chemotherapy and hormone therapy in treating older and\u002For frail women with breast cancer.",[38],"Breast Cancer",[40],"breast cancer","COMPLETED","2010-02-05",{"date":44,"type":32},"2010-02-09",{"date":46,"type":7},"2006-12",{"date":48,"type":49},"2007-10","ACTUAL",{"name":5,"class":6}]